David P Southwell Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

David P Southwell is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 31,660 shares of RCKT, which is worth approximately $99,095. The most recent transaction as insider was on Jun 18, 2025, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.7K

1807.23% 3M change

1807.23% 12M change

Total Value Held $99,095

DAVID P SOUTHWELL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2025	BUY Grant, award, or other acquisition	-	30,000 Added 48.65%	31,660 Common Stock
May 02 2024	SELL Bona fide gift	-	113,124 Reduced 98.55%	1,660 Common Stock
Apr 15 2024	SELL Open market or private sale	$240,500 $24.05 p/Share	10,000 Reduced 8.01%	114,784 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	$128,568 $4.34 p/Share	29,624 Added 19.19%	124,784 Common Stock
Apr 12 2024	SELL Open market or private sale	$1,728,300 $24.69 p/Share	70,000 Reduced 42.38%	95,160 Common Stock
Apr 12 2024	BUY Exercise of conversion of derivative security	$303,800 $4.34 p/Share	70,000 Added 29.77%	165,160 Common Stock

Also insider at

PTCT

PTC THERAPEUTICS, INC. Healthcare

TCRX

TScan Therapeutics, Inc. Healthcare

Chief Executive Officer

DPS